Phase Separation of Nur77 Mediates XS561-induced Apoptosis by Promoting the Formation of Nur77/Bcl-2 Condensates

Xiaohui Chen,Meichun Gao,Yongzhen Xia,Xin Wang,Jingbo Qin,Hongying He,Weirong Liu,Xiaowei Zhang,Shuangzhou Peng,Zhiping Zeng,Ying Su,Xiaokun Zhang
DOI: https://doi.org/10.1016/j.apsb.2023.11.017
IF: 14.903
2024-01-01
Acta Pharmaceutica Sinica B
Abstract:The orphan nuclear receptor Nur77 is a critical regulator of the survival and death of tumor cells. The pro-death effect of Nur77 can be regulated by its interaction with Bcl-2, resulting in conversion of Bcl-2 from a survival to killer. As Bcl-2 is overexpressed in various cancers preventing them from apoptosis and promoting their resistance to chemotherapy, targeting the apoptotic pathway of Nur77/Bcl-2 may lead to new cancer therapeutics. Here, we report our identification of XS561 as a novel Nur77 ligand that induces apoptosis of tumor cells by activating the Nur77/Bcl-2 pathway. In vitro and animal studies revealed an apoptotic effect of XS561 in a range of tumor cell lines including MDA-MB-231 triple-negative breast cancer (TNBC) and MCF-7/LCC2 tamoxifen-resistant breast cancer (TAMR) in a Nur77-dependent manner. Mechanistic studies showed XS561 potently induced the translocation of Nur77 from the nucleus to mitochondria, resulting in mitochondria-related apoptosis. Interestingly, XS561-induced accumulation of Nur77 at mitochondria was associated with XS561 induction of Nur77 phase separation and the formation of Nur77/Bcl-2 condensates. Together, our studies identify XS561 as a new activator of the Nur77/Bcl-2 apoptotic pathway and reveal a role of phase separation in mediating the apoptotic effect of Nur77 at mitochondria.
What problem does this paper attempt to address?